GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes

被引：23

作者：

Hill, Micah J. ^{[1
,2
]}

Chason, Rebecca J. ^{[1
,2
]}

Payson, Mark D. ^{[1
,2
]}

Segars, James H. ^{[2
]}

Csokmay, John M. ^{[1
,2
]}

机构：

[1] Walter Reed Natl Mil Med Ctr, Washington, DC USA

[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA

来源：

REPRODUCTIVE BIOMEDICINE ONLINE | 2012年 / 25卷 / 03期

关键词：

assisted reproduction; cancellation; GnRH antagonist rescue; infertility; IVF; OHSS; OVARIAN HYPERSTIMULATION SYNDROME; OOCYTE; WOMEN; FERTILIZATION; PREVENTION;

D O I：

10.1016/j.rbmo.2012.05.004

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Gonadotrophin-releasing hormone (GnRH) antagonist rescue is performed by replacing a GnRH agonist with a GnRH antagonist in patients with rapidly rising serum oestradiol who are at risk of ovarian hyperstimulation syndrome (OHSS) during stimulation. It results in a rapid reduction in serum oestradiol, allowing for the avoidance of cycle cancellation and the continuation of exogenous gonadotrophin administration. A total of 387 patients who underwent GnRH antagonist rescue for ovarian hyperresponse were compared with 271 patients who did not receive GnRH antagonist rescue and had oestradiol concentrations >4000 pg/ml on the day of human chorionic gonadotrophin (HCG) administration. GnRH antagonist rescue decreased the mean oestradiol concentration by 35% on the first day of use. There was no difference in oocyte maturity (82% versus 83%) or fertilization rate (69% versus 67%) between the antagonist rescue and comparison groups, respectively. The percentage of high-grade embryos on day 3 and the blastocyst development rate were also similar between groups. The live-birth rate was 41.9% in the antagonist rescue group and 36.9% in the comparison group. GnRH antagonist rescue enabled cycle completion with high live-birth rates in patients at risk for OHSS. GnRH antagonist was associated with high oocyte quality, blastocyst development and pregnancy. RBM Online (c) 2012, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

引用

页码：284 / 291

页数：8

共 17 条

[1] A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS [J].

Aboulghar, Mohamed A. ;

Mansour, Ragaa T. ;

Amin, Yahia M. ;

Al-Inany, Hesham G. ;

Aboulghar, Mona M. ;

Serour, Gamal I. .

REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 15 (03) :271-279

[2] Ovarian hyperstimulation syndrome [J].

不详 .

FERTILITY AND STERILITY, 2008, 90 :S188-S193

[3] Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "Tap early and often" versus hospitalization [J].

Csokmay, John M. ;

Yauger, Belinda J. ;

Henne, Melinda B. ;

Armstrong, Alicia Y. ;

Queenan, John T. ;

Segars, James H. .

FERTILITY AND STERILITY, 2010, 93 (01) :167-173

[4] Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [J].

Delvigne, A ;

Rozenberg, S .

HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :559-577

[5] THE OVARIAN HYPERSTIMULATION SYNDROME IN IN-VITRO FERTILIZATION - A BELGIAN MULTICENTRIC STUDY .1. CLINICAL AND BIOLOGICAL FEATURES [J].

DELVIGNE, A ;

DEMOULIN, A ;

SMITZ, J ;

DONNEZ, J ;

KONINCKX, P ;

DHONT, M ;

ENGLERT, Y ;

DELBEKE, L ;

DARCIS, L ;

GORDTS, S ;

PUTTEMANS, P ;

GERRIS, J ;

SCHOYSMAN, R ;

LEROY, F .

HUMAN REPRODUCTION, 1993, 8 (09) :1353-1360

[6] Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization [J].

Enskog, A ;

Henriksson, M ;

Unander, M ;

Nilsson, L ;

Brännström, M .

FERTILITY AND STERILITY, 1999, 71 (05) :808-814

[7]

Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004

[8] The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome [J].

Grossman, Lisa C. ;

Michalakis, Konstantinos G. ;

Browne, Hyacinth ;

Payson, Mark D. ;

Segars, James H. .

FERTILITY AND STERILITY, 2010, 94 (04) :1392-1398

[9] Treatment with gonadotropin-releasing hormone (GnRH) antagonists in women suppressed with GnRH agonist may avoid cycle cancellation in patients at risk for ovarian hyperstimulation syndrome [J].

Gustofson, RL ;

Larsen, FW ;

Bush, MR ;

Segars, JH .

FERTILITY AND STERILITY, 2006, 85 (01) :251-254

[10] Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome [J].

Gustofson, Robert L. ;

Segars, James H. ;

Larsen, Frederick W. .

HUMAN REPRODUCTION, 2006, 21 (11) :2830-2837

← 1 2 →